Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial

Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial

Abstract Objective To evaluate if daily oral 75 µg of Desogestrel (DSG) for 3 months prior to the insertion of etonogestrel-releasing contraceptive implant (ENG-IMPLANT) might help reduce its premature discontinuation. Results A total of 66 women were randomized in the ENG-IMPLANT group (26) and in...

Full description

Bibliographic Details
Main Authors: Valeria Lombardi Fäh, Rosa Catarino, Sarah Castillo, Maria Badda, Sibel Gezer-Dickschat, Friederike Thieringer, Sibil Tschudin, Manuela Viviano, Michal Yaron
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Research Notes
Subjects:
Desogestrel pill
Discontinuation
Long-acting reversible contraceptives (LARC)
Tolerance
Etonogestrel-releasing contraceptive implant
Online Access:https://doi.org/10.1186/s13104-023-06304-3

Internet

https://doi.org/10.1186/s13104-023-06304-3

Similar Items